Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What do international guidelines say about therapy?

R B Thakkar1, S Oparil,

  • 1Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, University of Alabama at Birmingham School of Medicine, 35294, USA. rthakkar15@yahoo.com

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|November 21, 2001
PubMed
Summary

Lifestyle modifications are key for hypertension management. Pharmacologic therapy for high blood pressure should be individualized based on patient profile and risk factors, with thiazide diuretics often recommended.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive Blood Pressure Management Preserves Functional Connectivity in Patients with Hypertension from the Systolic Blood Pressure Intervention Randomized Trial.

AJNR. American journal of neuroradiology·2023
Same author

Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.

Alimentary pharmacology & therapeutics·2016
Same author

Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis.

Alimentary pharmacology & therapeutics·2015
Same author

Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.

Journal of human hypertension·2014

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Review of international hypertension treatment guidelines from major health organizations.
  • Focus on guidelines published from 1997 onwards, accessible online.

Framework:

  • Comparison of blood pressure thresholds and therapeutic goals.
  • Evaluation of non-pharmacologic interventions and first-line pharmacologic agents.
  • Analysis of individualized treatment strategies and adjunctive therapies.

Implementation:

  • Strong emphasis on lifestyle modifications as a primary intervention for hypertension.
  • Advocacy for a trial of lifestyle changes before initiating drug therapy.
  • Pharmacologic treatment tailored to patient-specific factors like cardiovascular risk, comorbidities, and target-organ damage.

Related Experiment Videos

Implications:

  • Thiazide diuretics identified as a commonly recommended drug class due to outcome trial evidence.
  • Introduction of new strategies like low-dose combination therapy for initial treatment in select patients.
  • Personalized approach to managing hypertension is crucial for effective patient outcomes.